The influence of hormone receptor status and HER1 and HER2 expression on the response to neoadjuvant therapy in breast cancer patients

被引：0
|
作者：
Bonigliere, L. [1 ]
Torrisi, R. [1 ]
Pruneri, G. [1 ]
Colleoni, M. [1 ]
Viale, G. [1 ]
机构：
[1] European Inst Oncol, Milan, Italy
来源：
LABORATORY INVESTIGATION | 2008年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
97
引用
收藏
页码：24A / 24A
页数：1
相关论文
共 50 条
  • [41] IMPACT OF HORMONE RECEPTOR STATUS AND HER2 ON SURVIVAL OF TRIPLE NEGATIVE BREAST CANCER PATIENTS
    Xiao, H.
    Tan, F.
    Huang, Y.
    Feldman, J.
    Koniaris, L.
    Gummadi, S.
    Adunlin, G. B.
    Ali, A. A.
    VALUE IN HEALTH, 2013, 16 (03) : A131 - A131
  • [42] CLINICAL IMPORTANCE OF DISCORDANCE IN HORMONE RECEPTOR AND HER2/NEU STATUS AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER
    Ustaalioglu, B. B. Oven
    Vardar, F. Aker
    Bilici, A.
    Gurleyik, G.
    Erkol, B.
    Kefeli, U.
    ANNALS OF ONCOLOGY, 2014, 25
  • [43] Impact of hormone receptor and HER2 conversions on survival after neoadjuvant chemotherapy in breast cancer patients
    Ran Feng
    Lihui Pan
    Yarong Yao
    Jinnan Gao
    Xiaojun Zhang
    Oncology and Translational Medicine, 2025, 11 (02) : 73 - 80
  • [44] A phase 1 study of abemaciclib and niraparib as neoadjuvant therapy in hormone receptor positive (HR+) HER2 negative (HER2-) breast cancer
    Li, Allen
    Naik, Arpana
    Johnson, Nathalie
    Goodyear, Shaun
    Johnson, Brett
    Park, Byung
    Corless, Christopher
    Gray, Joe
    Mills, Gordon
    Mitri, Zahi
    CANCER RESEARCH, 2021, 81 (04)
  • [45] Cytogenetic analysis of Her1/EGFR, Her2/neu, Her3, and hEr4 receptor tyrosine kinases in breast cancer
    Sassen, A.
    Rochon, J.
    Wild, P.
    Hartmann, A.
    Hofstaedter, F.
    Schwarz, S.
    Brockhoff, G.
    CYTOMETRY PART A, 2007, 71A (07) : 515 - 515
  • [46] Concordance of HER2 and hormone receptor expression in primary and recurrent breast cancer
    Wirk, B
    Geiger, X
    Hillman, D
    Perez, EA
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S89 - S89
  • [47] Evolution and Clinical Significance of HER2 Status after Neoadjuvant Therapy for Breast Cancer
    Shang, Jiuyan
    Liu, Yueping
    LABORATORY INVESTIGATION, 2023, 103 (03) : S209 - S209
  • [48] Assessment of hormone receptor status and HER2 expression by fine needle aspiration biopsy in breast cancer
    Hussain, M
    Cangiarella, J
    Volm, M
    Harris, MN
    Roses, DF
    Berman, RS
    ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (01) : S54 - S55
  • [49] Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status
    Omarini, C.
    Kaleci, S.
    Guaitoli, G.
    Bettelli, S.
    Caprera, C.
    Manfredini, S.
    Caggia, F.
    Baschieri, M. C.
    Moscetti, L.
    Maiorana, A.
    Cascinu, S.
    Piacentini, F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [50] Validation of Magee equation in predicting response to neoadjuvant chemotherapy in breast cancer patients with hormone receptor positive and HER2 negative
    Saigosoom, N.
    O-charoenrat, P.
    Udompunturak, S.
    Sanguanraksa, D.
    BREAST, 2019, 44 : S73 - S73
12345